News About: Pharm. Industry
Mid-sized pharmaceutical companies have raised complaints over the Rebate Secret Survey
When it comes to the ‘Rebate Secret Survey’ conducted by the Korea Pharmaceutical Manufacturers Association (KPMA) to settle ethical management and rebate eradication, a part of the pharmaceutical industry has begun t...
A series of pharmaceutical companies pushing forward with IPOs once again this year
Many affiliated companies of pharmaceutical companies have attracted the pharmaceutical industry with IPO(Initial Public Offering); for instance, Kyongbo Pharm, which has passed the preliminary examination to enter th...
Will Pfizer and BMS work on the revival of Eliquis?
Co-marketing, joint operation or joint cultivation may lead to an immediate failure once cooperative companies start to consider it as a task of the other. In this context, outstanding multinational pharmaceutical com...
A gap in R&D investments among of pharmaceutical companies is going extreme
While some pharmaceutical companies have spent over 20% of their sales in investments for R&D to generate future sales, there are also pharmaceutical companies invest the formal amount of money, which are less than 1%...
The average current ratio of listed pharmaceutical companies was 193% while their cash mobilization power is satisfactory
Although most listed pharmaceutical companies received fine evaluations as to cash mobilization power, some companies were indicated to experience pressure for liquidity in case.
According to the YakupDotCom’s analys...
80 personnel including directives applied the GSK’s Early Retirement ProgramIt is observed that approximately 80 executives and employees have participated in the Early Retirement Program (ERP) as a part of the GSK’s reorganization.
According to the in...
|
15 pharmaceutical companies, such as Kyung Nam Pharm, exceeds 100% in debt ratios
As 1 out of 4 listed pharmaceutical companies have more debts than their capitol, the issue has been criticized as a problem in safety of their financial structure.
According to the YakupDotCom’s analysis result of t...
The pharmaceutical industry has made the incline rally as 5 companies, such as Chong Kun Dang, hit the ceiling
Is it because of the new drug development and expectations of performance in the foreign market? Stock price of the pharmaceutical industry has continuously made an incline rally again.
Stock price of 5 pharmaceutica...
Representative products of pharmaceutical companies with high energy
It is observed that representative products of domestic pharmaceutical companies have played huge roles in the 1st quarter of the year. Although main products generally showed decent performance with over KRW 10 billi...
Listed pharmaceutical companies spent 32.3% of their sales in sales management cost
It is criticized that although efforts of pharmaceutical companies to reduce sales management cost have been slowly reflected, high proportion of the cost have still been an obstacle for their profitability due to its...
